Comparation Of Ketorolac And Methadone
Phase 3
- Conditions
- Patients candidate for orthopedic Plating’s Surgery.
- Registration Number
- IRCT20190731044395N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
AGE 15-55years
No underlying disease
ASA CLASS I&II
General anesthesia
Plating’s Orthopedic Surgery’s cases
Exclusion Criteria
Drug addict
Preoperative hemodynamic unstability
Blood loss that needs Transfusion of Packed Red Cells
Take a drug that effects on hemodynamic
Informed consent not signed
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduced pain score in patients. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Visual acuity scale.;Heart rate. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Heart contraction by ECG monitor.;Blood pressure. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Blood pressure on monitor.;Nausea & Vomit. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Asking Patient.;Asking for morphine. Timepoint: Pain will be evaluated at the beginning of study and 0.5, 1 and 6 hours after intervention. Method of measurement: Number of doses patient asking for.
- Secondary Outcome Measures
Name Time Method